플루리 (PLUR) 주가

플루리(PLUR)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.08 (+0.00%), 시가총액 $0.04B, 52주 최저~최고 $2.92 ~ $5.79.

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to coronavirus Disease (COVID-19), peripheral artery disease, intermittent clau

핵심 지표

• 현재가: $1.08 (+0.00%)
• 시가총액: $0.04B
• 52주 최저~최고: $2.92 ~ $5.79
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

플루리의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

플루리 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 306.56
• 순이익률: 0.00%
• 영업이익률: -32.86%

자주 묻는 질문